Endotracheal Tubes Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI2691
Endotracheal Tubes Market size is set to show substantial expansion from 2021 to 2027 owing to the rise in the number of chronic diseases. The growing concerns over ventilator-associated pneumonia have paved way for antimicrobial and anti-coagulant-coated medical devices. The higher prevalence of chronic respiratory infections and the rising obligation for mechanical ventilation are some other major factors driving the market growth.
Furthermore, increasing progressions in nanobiotechnology and drug design along with the elevation in the number of surgical procedures is likely to compliment the product demand spurt through 2027.
Based on intubation, the market is segmented across orotracheal and nasotracheal. The demand for orotracheal intubation is anticipated to capture a significant revenue share driven by rising penetration in emergencies, like serious injuries and cardiac arrests. On account of their optimum comfortability and applicability, orotracheal intubation is gaining higher preference in patients. The growing need for less painful and easy-to-perform surgeries will additionally drive the market expansion.
Emergency treatment applications of endotracheal tubes are set to record considerable traction due to the rising prevalence of road accidents worldwide. According to the World Health Organization (WHO), more than 1.3 million people die from road traffic crashes every year. The increasing requirement to cater to inadequate ventilation and escalating cases of respiratory problems will influence the industry growth.
With regards to end-use, clinics are expected to bring remarkable gains for the market impelled by the rising occurrence of respiratory chronic ailments. As clinics serve fewer patients, they offer benefits, such as affordability, effective treatment measures, and extended time engagement with the affected individuals. The presence of reimbursement policies will further bolster the adoption of endotracheal tubes in these settings.
APAC endotracheal tubes market will garner momentum between 2021 to 2027 led by the booming population base and the surging instances of lung injuries and cancer in the region. The increasing per capita incomes have led to higher healthcare infrastructure advancements. Growing demand for coated endotracheal tubes will also foster the regional progression.
Some of the major suppliers of endotracheal tubes include Fuji System, Smiths Group, Armstrong Medical (Eakin Healthcare Group Ltd), Hospiteknik Healthcare, Teleflex, Brio Device, Airway Innovations, Medtronic, Venner Medical, Parker Medical, Well Lead, Enox Biopharma, Becton Dickinson and Company, Medline Industries, Sewoon Medical, Sonoma Pharmaceutical, Bactiguard, ConvaTec, Hollister (Abercrombie & Fitch, Abercrombie & Fitch Management Co) and C.R. Bard (BD).
These firms are actively implementing business and growth strategies, such as acquisitions, partnerships, investments, and mergers, along with novel product launches and product expansions to proliferate their portfolio and geographical presence.
For instance, in April 2020, Hydromer partnered with N8 Medical to become the exclusive coating supplier as well as manufacturing partner for the latter’s CeraShield™ Endotracheal Tube, which is used in the treatment of mechanically ventilated COVID-19 patients across Canada.
In another instance, in August 2020, Health Canada provided its approval through an Interim Order for Bactiguard’s endotracheal tubes used in the prevention of the COVID-19 infection. The novel device helps in the reduction of the risks related to secondary infections in critically ill patients.
Influence of COVID-19 pandemic on the market outlook
The present COVID-19 outbreak not only constituted an unprecedented setback on the global economy but also gave way for massive hurdles across most industrial sectors owing to the shuttering of manufacturing activities. However, the overwhelming infection count acted as a booster to the acceptance of endotracheal tubes to meet the escalating need for intubation and ventilation to tend to the COVID-19 patients as well as to limit the enhanced risks of cross-infections. This attracted a large number of growth opportunities for numerous industry players.
Endotracheal Tubes Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Kilotons from 2016 to 2027, for the following segments:
Market by Intubation, 2013-2024 (USD Million)
- Orotracheal intubation
- Nasotracheal intubation
Market by Type, 2013-2024 (USD Million)
- Regular tubes
- Reinforced/armoured tubes
- Coated tubes
- Laser resistant tubes
- Double lumen tubes
Market by Application, 2013-2024 (USD Million)
- Emergency treatment
Market by End-use, 2013-2024 (USD Million)
- Ambulatory Surgical Centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability